These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 33030064)

  • 1. The randomised Oslo study of renal denervation
    Bergland OU; Søraas CL; Larstorp ACK; Halvorsen LV; Hjørnholm U; Hoffman P; Høieggen A; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):41-50. PubMed ID: 33030064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE; Hoffmann P; Larstorp AC; Fossum E; Brekke M; Kjeldsen SE; Gjønnæss E; Hjørnholm U; Kjaer VN; Rostrup M; Os I; Stenehjem A; Høieggen A
    Hypertension; 2014 May; 63(5):991-9. PubMed ID: 24591332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of patients undergoing renal sympathetic denervation.
    Zeijen VJM; Feyz L; Nannan Panday R; Veen K; Versmissen J; Kardys I; Van Mieghem NM; Daemen J
    Clin Res Cardiol; 2022 Nov; 111(11):1256-1268. PubMed ID: 35851428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation for mild-moderate treatment-resistant hypertension : A timely intervention?
    Chen S; Kiuchi MG; Schmidt B; Hoye NA; Acou WJ; Liu S; Chun KRJ; Pürerfellner H
    Herz; 2019 Aug; 44(5):412-418. PubMed ID: 29255910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation in moderate treatment-resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Ditting T; Sobotka PA; Veelken R; Spies A; Ukena C; Laufs U; Uder M; Böhm M; Schmieder RE
    J Am Coll Cardiol; 2013 Nov; 62(20):1880-6. PubMed ID: 23850901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications.
    Pathak A; Rudolph UM; Saxena M; Zeller T; Müller-Ehmsen J; Lipsic E; Schmieder RE; Sievert H; Halbach M; Sharif F; Parise H; Fischell TA; Weber MA; Kandzari DE; Mahfoud F
    EuroIntervention; 2023 Sep; 19(7):602-611. PubMed ID: 37427416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of catheter ablation renal denervation in "mild" resistant hypertension.
    Chen S; Kiuchi MG; Acou WJ; Derndorfer M; Wang J; Li R; Kollias G; Martinek M; Kiuchi T; Pürerfellner H; Liu S
    J Clin Hypertens (Greenwich); 2017 Apr; 19(4):361-368. PubMed ID: 28266770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular and renal hemodynamic changes after renal denervation.
    Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON; Vase H; Bech JN; Christensen KL; Buus NH; Schroeder AP; Lederballe O; Rickers H; Kampmann U; Poulsen PL; Hansen KW; Btker HE; Peters CD; Engholm M; Bertelsen JB; Lassen JF; Langfeldt S; Andersen G; Pedersen EB; Kaltoft A
    J Hypertens; 2016 Aug; 34(8):1639-47. PubMed ID: 27228432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Alcohol-Mediated Renal Denervation on Blood Pressure in the Presence of Antihypertensive Medications: Primary Results From the TARGET BP I Randomized Clinical Trial.
    Kandzari DE; Weber MA; Pathak A; Zidar JP; Saxena M; David SW; Schmieder RE; Janas AJ; Langer C; Persu A; Mendelsohn FO; Ameloot K; Foster M; Fischell TA; Parise H; Mahfoud F
    Circulation; 2024 Jun; 149(24):1875-1884. PubMed ID: 38587557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension.
    Bergo KK; Larstorp AC; Hoffmann P; Hjørnholm U; Cataliotti A; Høieggen A; Rostrup M; Fadl Elmula FEM
    Blood Press; 2021 Feb; 30(1):31-40. PubMed ID: 32633141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure.
    Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A
    Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
    Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
    Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided ozone-mediated lumbar-renal sympathetic denervation for resistant hypertension treatment: A pilot single-arm clinical trial.
    Li L; Liu J; Huang B; Zhang Y; Zeng F; Tian P; Chen X; Li B; Wang Y; Yang H; Xiao X; Chen S; Jiang P; Wang J; Huang Y
    Cardiovasc Revasc Med; 2024 Oct; 67():51-57. PubMed ID: 38704325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE; Jin Y; Yang WY; Thijs L; Lu YC; Larstorp AC; Persu A; Sapoval M; Rosa J; Widimský P; Jacobs L; Renkin J; Petrák O; Chatellier G; Shimada K; Widimský J; Kario K; Azizi M; Kjeldsen SE; Staessen JA;
    Blood Press; 2015; 24(5):263-74. PubMed ID: 26194721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L; Li C; Li Z; Li Q; Liu C; Sun X; He Q; Xia DS; Xia D; Lu C
    J Hypertens; 2024 May; 42(5):801-808. PubMed ID: 38164953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistant hypertension: Renal denervation or pharmacovigilance? Insights from a renal denervation screening program.
    Ojrzanowski M; Kasprzak JD; Peruga JZ; Kurpesa M; Jankowski Ł; Sahni S; Plewka M
    Adv Clin Exp Med; 2019 Nov; 28(11):1525-1530. PubMed ID: 31693316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis.
    Sobreira LER; Bezerra FB; Sano VKT; de Oliveira Macena Lôbo A; Cardoso JHCO; Kelly FA; de Moraes FCA; Consolim-Colombo FM
    High Blood Press Cardiovasc Prev; 2024 Jul; 31(4):329-340. PubMed ID: 38890242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.